US 10982215
Polynucleotide agents targeting programmed cell death 1 ligand 1 (PD-L1) and methods of use thereof
granted A61KA61K31/7088A61K31/712
Quick answer
US patent 10982215 (Polynucleotide agents targeting programmed cell death 1 ligand 1 (PD-L1) and methods of use thereof) held by Alnylam Pharmaceuticals, Inc. expires Mon Apr 15 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Alnylam Pharmaceuticals, Inc.
- Grant date
- Tue Apr 20 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 15 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K31/7088, A61K31/712, A61K31/7125, A61K45/06